Approved by Ministry of Ayush, Govt. of India for adjuvant treatment of mild to moderate COVID-19 Approved by Ministry of Ayush, Govt. of India for adjuvant treatment of mild to moderate COVID-19 Approved by Ministry of Ayush, Govt. of India for adjuvant treatment of mild to moderate COVID-19
Approved by Ministry of Ayush, Govt. of India for adjuvant treatment of mild to moderate COVID-19 Approved by Ministry of Ayush, Govt. of India for adjuvant treatment of mild to moderate COVID-19 Approved by Ministry of Ayush, Govt. of India for adjuvant treatment of mild to moderate COVID-19

REMEDIUM THERAPEUTICS

DISCOVERING BREAKTHROUGH DRUGS

REMEDIUM THERAPEUTICS

DISCOVERING BREAKTHROUGH DRUGS

We are a leading, research driven, drug development firm that aims to provide high quality remedies to effectively manage diseases and improve quality of life. By applying systematic and rational scientific processes towards research, development and manufacturing, Remedium aims to provide high-quality herbal drugs to effectively manage infectious diseases. Remedium’s drive to understand phytochemicals, their chemistry and pharmacology may also reveal critical insights required to design and develop novel semi-synthetic and synthetic drugs with improved efficacy and reduced adverse effects.

COROQUIL-Zn

BREAKTHROUGH  DRUGS FOR LUNGS SUPPORT SYSTEM

COROQUIL-Zn

BREAKTHROUGH DRUGS
FOR LUNG SUPPORT SYSTEM

The recent pandemic is a testimony to the fact that now, more than ever, there is a need to carry out research and eventually develop methods and remedies that prevent and cure modern day ailments.

COROQUIL-Zn, a breakthrough drug is the first step in that direction. COROQUIL-Zn, a cli nically tested drug, has been developed using edible plant extracts listed in Materia Medica and Ayurvedic Pharmacopoeia.

COROQUIL-Zn is an efficacious  mechanism for lung support. Using in silico modular docking and cell based studies, we identified select phytoconstituents (present in different plants) for their ability to interfere with the binding of the viral Spike S protein receptor binding domain (RBD) in the Coronavirus with host ACE2 receptors in the human cell. We formulated COROQUIL-Zn using plant extracts enriched with active phytoconstituents.

COROQUIL-Zn supports in modulating immunity against inflammatory diseases with respiratory distress – including cough, fever, fatigue, sore throat and gastrointestinal inflammation.

KNOW MORE

MAKING A DIFFERENCE

Play Video

RJ Sudha (of Tamizh Suvai radio) interviews Dr. Pavithra Venkatagopalan and Pat

Krishnan on COROQUIL-Zn

TESTIMONIALS

Contacts

© 2021, Remedium Therapeutics Private Limited. All Rights Reserved